Treatment situation for newly diagnosed multiple myeloma (MM) patients in Germany (GER). First results from a representative multicentre treatment survey.

被引：0
|
作者：
Freund, MRF
Knauf, W
Goldschmidt, H
Einsele, H
Nowrousian, MR
Berdel, WE
Poenisch, W
Straka, C
Kellermann, L
Bammer, S
Angermund, R
机构：
[1] Univ Rostock, Rostock, Germany
[2] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[3] Univ Heidelberg, D-6900 Heidelberg, Germany
[4] Univ Wurzburg, D-97070 Wurzburg, Germany
[5] Univ Essen Gesamthsch, Essen, Germany
[6] Univ Munster, D-4400 Munster, Germany
[7] Univ Leipzig, D-7010 Leipzig, Germany
[8] Univ Munich, Klinikum Innenstadt, D-8000 Munich, Germany
[9] Oncol Informat Serv, Freiburg, Germany
[10] ORTHO BIOTECH, Neuss, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5158
引用
收藏
页码：372B / 373B
页数：2
相关论文
共 50 条
  • [21] Treatment Patterns from 2009 to 2015 in Patients with Newly Diagnosed Multiple Myeloma in the United States: A Report from the Connect MM Registry
    Rifkin, Robert M.
    Abonour, Rafat
    Durie, Brian G. M.
    Gasparetto, Cristina J.
    Jagannath, Sundar
    Narang, Mohit
    Shah, Jatin J.
    Terebelo, Howard R.
    Toomey, Kathleen
    Kitali, Amani
    Zafar, Faiza
    Srinivasan, Shankar
    Hardin, James W.
    BLOOD, 2016, 128 (22)
  • [22] European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
    Engelhardt, Monika
    Terpos, Evangelos
    Kleber, Martina
    Gay, Francesca
    Waesch, Ralph
    Morgan, Gareth
    Cavo, Michele
    van de Donk, Niels
    Beilhack, Andreas
    Bruno, Benedetto
    Johnsen, Hans Erik
    Hajek, Roman
    Driessen, Christoph
    Ludwig, Heinz
    Beksac, Meral
    Boccadoro, Mario
    Straka, Christian
    Brighen, Sara
    Gramatzki, Martin
    Larocca, Alessandra
    Lokhorst, Henk
    Magarotto, Valeria
    Morabito, Fortunato
    Dimopoulos, Meletios A.
    Einsele, Hermann
    Sonneveld, Pieter
    Palumbo, Antonio
    HAEMATOLOGICA, 2014, 99 (02) : 232 - 242
  • [23] Bortezomib Retreatment in Relapsed Multiple Myeloma (MM): Results from a Binational, Multicenter Retrospective Survey.
    Hrusovsky, Irena
    Emmerich, Berthold
    von Rohr, Albert
    Engelhardt, Monika
    Voegeli, Jerome
    Taverna, Christian
    Olie, Robert
    Pliskat, Harold
    Frohn, Claas
    Hess, Georg
    BLOOD, 2008, 112 (11) : 957 - 958
  • [24] Changes in treatment of patients with multiple myeloma in Germany - results from the MYRIAM registry
    Engelhardt, M.
    Knauf, W.
    Lipke, J.
    Reiser, M.
    Doerfel, S.
    Kortuem, M.
    Schlag, R.
    von der Heyde, E.
    La Rosee, P.
    Pfannes, R.
    Houet, L.
    Medinger, T.
    Jaenicke, M.
    Marschner, N.
    Dechow, T.
    Einsele, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 108 - 108
  • [25] Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis
    J Lu
    J Lu
    W Chen
    Y Huo
    X Huang
    J Hou
    Blood Cancer Journal, 2014, 4 : e239 - e239
  • [26] Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis
    Lu, J.
    Lu, J.
    Chen, W.
    Huo, Y.
    Huang, X.
    Hou, J.
    BLOOD CANCER JOURNAL, 2014, 4 : e239 - e239
  • [27] The impact of age in an intensive treatment of newly diagnosed multiple myeloma (MM) patients: Results of the prospective multicentric spanish trial GEM-2000
    Garcia, A.
    Sureda, A.
    Lahuerta, J. J.
    de la Rubia, J.
    Garcia-Sanz, R.
    Martinez, R.
    Garcia-Larana, J.
    de Arriba, F.
    Ribera, J. M.
    Hernandez, M. T.
    Escoda, L.
    Carrera, D.
    Terol, M. J.
    Besalduch, J.
    Casado, F.
    Palomera, L.
    Blade, J.
    San Miguel, J. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 190 - 190
  • [28] Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
    Bahlis, N. J.
    Corso, A.
    Mugge, L-O
    Shen, Z-X
    Desjardins, P.
    Stoppa, A-M
    Decaux, O.
    de Revel, T.
    Granell, M.
    Marit, G.
    Nahi, H.
    Demuynck, H.
    Huang, S-Y
    Basu, S.
    Guthrie, T. H.
    Ervin-Haynes, A.
    Marek, J.
    Chen, G.
    Facon, T.
    LEUKEMIA, 2017, 31 (11) : 2435 - 2442
  • [29] Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
    N J Bahlis
    A Corso
    L-O Mugge
    Z-X Shen
    P Desjardins
    A-M Stoppa
    O Decaux
    T de Revel
    M Granell
    G Marit
    H Nahi
    H Demuynck
    S-Y Huang
    S Basu
    T H Guthrie
    A Ervin-Haynes
    J Marek
    G Chen
    T Facon
    Leukemia, 2017, 31 : 2435 - 2442
  • [30] Treatment Patterns From 2009-2015 in Patients With Newly Diagnosed Multiple Myeloma in the United States: A Report From the Connect® MM Registry
    Rifkin, Robert
    Abonour, Rafat
    Durie, Brian
    Gasparetto, Cristina
    Jagannath, Sundar
    Narang, Mohit
    Shah, Jatin
    Terebelo, Howard
    Toomey, Kathleen
    Kitali, Amani
    Zafar, Faiza
    Srinivasan, Shankar
    Hardin, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E20 - E21
12345